Fractional Exhaled Nitric Oxide is Associated with the Severity of Stable COPD

References

• Collaborators GCRD. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med 2017;5(9):691–706.
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. 2013-02-15. doi:10.1164/rccm.201204-0596PP.
   PubMed Web of Science ®Google Scholar
• Singh D, Edwards L, Tal-Singer R, et al. Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Respir Res. 2010;11(1):77. 2010-06-15. doi:10.1186/1465-9921-11-77.
   PubMedGoogle Scholar
• Sethi S, Mahler DA, Marcus P, et al. Inflammation in COPD: implications for management. Am J Med. 2012;125(12):1162–1170. doi:10.1016/j.amjmed.2012.06.024.
   PubMed Web of Science ®Google Scholar
• Hastie AT, Martinez FJ, Curtis JL, et al. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017;5(12):956–967. doi:10.1016/S2213-2600(17)30432-0.
   PubMed Web of Science ®Google Scholar
• Tworek D, Majewski S, Szewczyk K, et al. The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD. Respir Res. 2018;19(1):108. doi:10.1186/s12931-018-0807-y.
   PubMedGoogle Scholar
• Negewo NA, McDonald VM, Baines KJ, et al. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. COPD. 2016;11:1495–1504. 2016-01-20. doi:10.2147/COPD.S100338.
   Google Scholar
• Couillard S, Larivée P, Courteau J, et al. Eosinophils in COPD exacerbations are associated with increased readmissions. Chest. 2017;151(2):366–373. doi:10.1016/j.chest.2016.10.003.
   PubMed Web of Science ®Google Scholar
• Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12(1):1–8. doi:10.1186/1465-9921-12-127.
   PubMedGoogle Scholar
• Zeiger RS, Tran TN, Butler RK, et al. Relationship of blood eosinophil count to exacerbations in chronic obstructive pulmonary disease. J Allergy Clin Immunol Pract. 2018;6(3):944–954. 2018-05-01. doi:10.1016/j.jaip.2017.10.004.
   PubMed Web of Science ®Google Scholar
• Casanova C, Celli BR, De-Torres JP, et al. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD. Eur Respir J. 2017;50(5):1701162. doi:10.1183/13993003.01162-2017.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for prevention, diagnosis and management of chronic obstructive pulmonary disease, 2019.
   Google Scholar
• Yun JH, Lamb A, Chase R, et al. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2018;141(6):2037–2047.
   PubMed Web of Science ®Google Scholar
• Crespo A, Giner J, Torrejón M, et al. Clinical and inflammatory features of asthma with dissociation between fractional exhaled nitric oxide and eosinophils in induced sputum. J Asthma. 2016;53(5):459–464. doi:10.3109/02770903.2015.1116086.
   PubMed Web of Science ®Google Scholar
• Alcázarnavarrete B, Romeropalacios PJ, Ruizsancho A, et al. Diagnostic performance of the measurement of nitric oxide in exhaled air in the diagnosis of COPD phenotypes. Nitric Oxide. 2016;54:67–72.
   PubMed Web of Science ®Google Scholar
• Arif AA, Mitchell C. Use of exhaled nitric oxide as a biomarker in diagnosis and management of chronic obstructive pulmonary disease. J Prim Care Community Health. 2016;7(2):102–106. doi:10.1177/2150131915624922.
   PubMed Web of Science ®Google Scholar
• Bazeghi N, Gerds TA, Budtz-Jorgensen E, et al. Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD. Respir Med. 2011;105(9):1338–1344. 2011-09-01. doi:10.1016/j.rmed.2011.03.015.
   PubMed Web of Science ®Google Scholar
• Alcazar-Navarrete B, Ruiz RO, Conde BP, et al. Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD. Eur Respir J. 2018;51(1):1701457.
   PubMed Web of Science ®Google Scholar
• Jian W, Gao Y, Hao C, et al. Reference values for spirometry in Chinese aged 4–80 years. J Thorac Dis. 2017;9(11):4538–4549. doi:10.21037/jtd.2017.10.110.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005; 2005-08-0126(2):319–338. doi:10.1183/09031936.05.00034805.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society ERS. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005;171(8):912–930.
   PubMed Web of Science ®Google Scholar
• Colak Y, Afzal S, Nordestgaard BG, et al. Combined value of exhaled nitric oxide and blood eosinophils in chronic airway disease: the Copenhagen General Population Study. Eur Respir J. 2018;52(2):1800616. doi:10.1183/13993003.00616-2018.
   PubMed Web of Science ®Google Scholar
• Watz H, Tetzlaff K, Wouters EF, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med. 2016;4(5):390–398. doi:10.1016/S2213-2600(16)00100-4.
   PubMed Web of Science ®Google Scholar
• Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009; 360(10):973–984. doi:10.1056/NEJMoa0808991.
   PubMed Web of Science ®Google Scholar
• Donohue JF, Herje N, Crater G, et al. Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study. Int J Chron Obstr Pulm Dis. 2014;9:745–751.
   PubMed Web of Science ®Google Scholar
• Chang M, Shao B, Liu Y, et al. Analysis of allergens in 5 473 patients with allergic diseases in Harbin, China. Biomed Environ Sci. 2013;26(11):886–893. doi:10.3967/bes2013.017.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883.
   PubMed Web of Science ®Google Scholar
• Singh D, Kolsum U, Brightling CE, et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44(6):1697–1700. doi:10.1183/09031936.00162414.
   PubMed Web of Science ®Google Scholar
• Scott M, Raza A, Karmaus W, et al. Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study. Thorax. 2010;65(3):258–262. doi:10.1136/thx.2009.125443.
   PubMed Web of Science ®Google Scholar